The KRAS G12D Inhibitor Pipeline Grows - PubMed
5 hours ago
- #Clinical Trial
- #Oncology
- #KRAS G12D
- At the ASCO Annual Meeting, early clinical data for several KRAS G12D-selective inhibitors (RNK08594, GFH375, DN022150) were presented, showing promise for treating solid tumors like pancreatic ductal adenocarcinoma and non-small cell lung cancer.